Evidence map›Paper›PMID 34007130›Full record

ReviewWorld journal of gastroenterology2021

Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.

John Gubatan, Steven Levitte, Akshar Patel, Tatiana Balabanis, Mike T Wei, Sidhartha R Sinha

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John GubatanDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States. jgubatan@stanford.edu.
Steven LevitteDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Akshar PatelDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Tatiana BalabanisDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Mike T WeiDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Sidhartha R SinhaDivision of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Stanford Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a complex and multifaceted disorder of the gastrointestinal tract that is increasing in incidence worldwide and associated with significant morbidity. The rapid accumulation of large datasets from electronic health records, high-definition multi-omics (including genomics, proteomics, transcriptomics, and metagenomics), and imaging modalities (endoscopy and endomicroscopy) have provided powerful tools to unravel novel mechanistic insights and help address unmet clinical needs in IBD. Although the application of artificial intelligence (AI) methods has facilitated the analysis, integration, and interpretation of large datasets in IBD, significant heterogeneity in AI methods, datasets, and clinical outcomes and the need for unbiased prospective validations studies are current barriers to incorporation of AI into clinical practice. The purpose of this review is to summarize the most recent advances in the application of AI and machine learning technologies in the diagnosis and risk prediction, assessment of disease severity, and prediction of clinical outcomes in patients with IBD.

Indexed as

ColitisInflammatory Bowel DiseasesArtificial IntelligenceHumansMetagenomicsProspective StudiesArtificial intelligenceClinical outcomesCrohn’s diseaseInflammatory bowel diseaseMachine learningUlcerative colitis

Identifiers

PMID34007130
PMCPMC8108036
OpenAlexW3157079437

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.